Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Firestein

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Genes & Development|May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthAdam S Adler, Mark L McCleland, Sharon Yee, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Communications Biology|June 5, 2025
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell linesIan Y Luk, Jennifer K Mooi, Dmitri Mouradov, et al.
Cell|June 19, 2007
Integrative genomic approaches identify IKBKE as a breast cancer oncogeneJesse S Boehm, Jean J Zhao, Jun Yao, et al.
Nature Communications|May 9, 2014
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancerJinfeng Liu, Mark McCleland, Eric W Stawiski, et al.
Science Translational Medicine|January 14, 2026
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline gliomaHolly Holliday, Aaminah Khan, Anahid Ehteda, et al.
Nature|September 17, 2008
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activityRon Firestein, Adam J Bass, So Young Kim, et al.
Cancer Cell|May 18, 2013
Oncogenic ERBB3 mutations in human cancersBijay S Jaiswal, Noelyn M Kljavin, Eric W Stawiski, et al.
Nature Chemical Biology|August 2, 2016
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibitionAaron Boudreau, Hans E Purkey, Anna Hitz, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Genes & Development|May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthAdam S Adler, Mark L McCleland, Sharon Yee, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Communications Biology|June 5, 2025
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell linesIan Y Luk, Jennifer K Mooi, Dmitri Mouradov, et al.
Cell|June 19, 2007
Integrative genomic approaches identify IKBKE as a breast cancer oncogeneJesse S Boehm, Jean J Zhao, Jun Yao, et al.
Nature Communications|May 9, 2014
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancerJinfeng Liu, Mark McCleland, Eric W Stawiski, et al.
Science Translational Medicine|January 14, 2026
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline gliomaHolly Holliday, Aaminah Khan, Anahid Ehteda, et al.
Nature|September 17, 2008
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activityRon Firestein, Adam J Bass, So Young Kim, et al.
Cancer Cell|May 18, 2013
Oncogenic ERBB3 mutations in human cancersBijay S Jaiswal, Noelyn M Kljavin, Eric W Stawiski, et al.
Nature Chemical Biology|August 2, 2016
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibitionAaron Boudreau, Hans E Purkey, Anna Hitz, et al.
Pageof 7